Scintigraphic evaluation of cardiac metabolism in multicentric Castleman's disease

Internal Medicine

Volumn 43, Issue 6, 2004, Pages 490-492

  Matsuo, Shinro ^a   Nakamura, Yasuyuki ^a   Nakae, Ichiro ^a   Matsumoto, Tetsuya ^a   Takada, Masahiko ^a   Murata, Kiyoshi ^a   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

BMIPP; Multicentric Castleman's disease cardiomyopathy

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; TETROFOSMIN TC 99M;

AGED; ANGIOCARDIOGRAPHY; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; FATTY ACID METABOLISM; FEMALE; GATED IMAGING; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE BIOPSY; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; METABOLIC DISORDER; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; FATTY ACIDS; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HEART FAILURE, CONGESTIVE; HUMANS; IODOBENZENES; METABOLIC DISEASES; MYOCARDIUM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 3242743733     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.490     Document Type: Article

References (14)

1. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 20: 636-647, 1993.
2. Kingsmore SF, Silva OE, Hall BD, Sheldon EA, Cripe LD, St Clair EW. Presentation of multicentric Castleman's disease with sicca syndrome, cardiomyopathy, palmar and plantar rash. J Rheumatol 20: 1588-1591, 1993
3. Stansby G, Hilson A, Hamilton G. Gallium scintigraphy in the diagnosis and management of multifocal Castleman's disease. Br J Radiol 64: 165-167, 1991.
4. Matsuo S, Nakamura Y, Takahashi M, Mitsunami K, Kinoshita M. Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia. Jpn Circ J 62: 167-172, 1998.
5. Nishimoto N, Sasai M, Shima Y, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody theraphy. Blood 95: 56-61, 2000.
6. Nishi J, Maruyama I. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Leuk Lymphoma 38: 387-394, 2000.
7. Belec L, Mohamed AS, Authier FJ, et al. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. Blood 93: 3643-3653, 1999.
8. Tanus T, Miller HJ. POEMS syndrome presenting with cardiomegaly and cardiomyopathy. J Intern Med 231: 445-448, 1992.
9. Nishimura T, Nishimura S, Kajiya T, et al. Prediction of functional recovery and prognosis in patients with acute myocardial infarction by 123I-BMIPP and 201Tl myocardial single photon emission computed tomography: a multicenter trial. Ann Nucl Med 12: 237-248, 1998.
10. Kawamoto M, Tamaki N, Yonekura Y, et al. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 8: 47-54, 1994.
11. Matsuo S, Nakamura Y, Matsumoto T, Takahashi M, Kinoshita M. Detection of coronary microvascular disease by means of cardiac scintigraphy. Can J Cardiol 18: 183-186, 2002.
12. Matsuo S, Nakamura Y, Matsui T, Matsumoto T, Kinoshita M. Detection of denervated but viable myocardium in cardiac sarcoidosis with I-123 MIBG and Tl-201 SPECT imaging. Ann Nucl Med 15: 373-375, 2001.
13. Matsuo S, Nakae I, Nakamura Y, Horie M. Viable but denervated myocardium in a patient with eosinophilic myocarditis. International Medical Journal 10: 57, 2003.
14. Tsujimura E, Kusuoka H, Fukuchi K, et al. Changes in perfusion and fatty acid metabolism of rat heart with autommume myocarditis. Ann Nucl Med 14: 361-367, 2000.